Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil

NCT01365091 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Saxagliptin/metformin fixed-dose combination (FDC)
DRUG: Saxagliptin
DRUG: Metformin extended-release (XR)
DRUG: Saxagliptin/Metformin FDC
DRUG: Metformin

Sponsor

AstraZeneca